SEC Form 6-K filed by argenx SE
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 | ||||||||||||||
FORM 6-K | ||||||||||||||
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of October 2024 Commission File Number: 001-38097 | ||||||||||||||
ARGENX SE | ||||||||||||||
(Translation of registrant’s name into English) | ||||||||||||||
Laarderhoogteweg 25 1101 EB Amsterdam, the Netherlands | ||||||||||||||
(Address of principal executive offices) | ||||||||||||||
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ⌧ Form 40-F ☐ | ||||||||||||||
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (1): ☐ | ||||||||||||||
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐ | ||||||||||||||
EXPLANATORY NOTE | ||||||||||||||
On October 31, 2024, argenx SE (the “Company’’) issued a press release and investor presentation, copies of which are attached hereto as Exhibits 99.1 and 99.2, respectively, and are incorporated by reference herein. | ||||||||||||||
The information contained in this Current Report on Form 6-K, including Exhibit 99.1 and Exhibit 99.2, shall be deemed to be incorporated by reference into the Company’s Registration Statements on Forms F-3 (File No. 333-258251) and S-8 (File Nos. 333-225375, 333-258253, and 333-274721), and to be part thereof from the date on which this Current Report on Form 6-K is filed, to the extent not superseded by documents or reports subsequently filed or furnished. |
EXHIBITS | ||||||||
Exhibit | Description | |||||||
99.2 |
ARGENX SE | ||||||||
Date: October 31, 2024 | By: | /s/ Hemamalini (Malini) Moorthy | ||||||
Hemamalini (Malini) Moorthy | ||||||||
General Counsel | ||||||||